CARDOZA GEORGE sold $4K of SOPH
CARDOZA GEORGE (Chief Financial Officer) sold 774 shares of SOPHiA GENETICS SA (SOPH) at $5.38 on 2026-06-22 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a fresh datapoint on officer selling activity but does not include any new operational or financial information about SOPHiA.
Market read
This is primarily a sentiment/positioning datapoint (insider selling) with low expected impact absent additional company-specific catalysts.
What to watch
Traders may over-weight small insider sales; the more informative signal would be repeated consecutive sales, changes in trading plans, or insider buys—none are provided here.
Background
The article is an SEC Form 4 insider transaction disclosure for SOPHiA GENETICS SA.
Ticker impact
SOPHiA GENETICS CFO George Cardoza sold 774 shares in an open-market transaction at $5.3795 on 2026-06-22 under a 10b5-1 plan.
Likely limited near-term impact; any effect should be small and short-lived unless follow-on selling accelerates.
The filing is a pre-arranged 10b5-1 sale by an officer, with modest dollar value (~$4.2k) and no accompanying company-specific news (guidance, contracts, litigation, or operational updates).
Market effects
No clear sector read-through; this is a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity/compensation mechanics rather than bearish expectations.
Key entities
- issuerSOPHiA GENETICS SA
Subject of the Form 4 insider transaction; CFO George Cardoza sold shares under a 10b5-1 plan.
- insiderCARDOZA GEORGE
CFO who executed an open-market sale of 774 shares on 2026-06-22.
